Menu
Consolidated Income Statement1
Show table28.5 KB EXCEL
€ million |
Note |
2015 |
2014 |
Net sales |
➞ 8 |
12,844.7 |
11,362.8 |
Cost of sales |
➞ 9 |
– 4,076.3 |
– 3,526.4 |
(of which: amortization of intangible assets)2 |
|
(– 166.6) |
(– 94.0) |
Gross profit |
|
8,768.4 |
7,836.4 |
|
|
|
|
Marketing and selling expenses |
➞ 10 |
– 4,049.5 |
– 3,589.1 |
(of which: amortization of intangible assets)2 |
|
(– 778.9) |
(– 719.0) |
Administration expenses |
|
– 719.9 |
– 608.6 |
Research and development costs |
➞ 11 |
– 1,709.2 |
– 1,703.7 |
(of which: amortization of intangible assets)2 |
|
(– 2.7) |
(– 3.8) |
Other operating income |
➞ 12 |
470.7 |
564.4 |
Other operating expenses |
➞ 13 |
– 917.3 |
– 737.4 |
Operating result (EBIT) |
|
1,843.2 |
1,762.0 |
|
|
|
|
Financial result |
➞ 14 |
– 356.7 |
– 205.0 |
Profit before income tax |
|
1,486.5 |
1,557.0 |
|
|
|
|
Income tax |
➞ 15 |
– 368.0 |
– 392.2 |
Profit after tax from continuing operations |
|
1,118.5 |
1,164.8 |
Profit after tax from discontinued operations |
|
5.6 |
– |
Profit after tax |
|
1,124.1 |
1,164.8 |
|
|
|
|
of which: attributable to Merck KGaA shareholders (net income) |
|
1,114.8 |
1,157.3 |
of which: attributable to non-controlling interests |
➞ 25 |
9.3 |
7.5 |
|
|
|
|
Earnings per share (in €) |
➞ 16 |
|
|
basic |
|
2.56 |
2.66 |
- thereof from continuing operations |
|
2.55 |
2.66 |
- thereof from discontinued operations |
|
0.01 |
– |
|
|
|
|
diluted |
|
2.56 |
2.66 |
- thereof from continuing operations |
|
2.55 |
2.66 |
- thereof from discontinued operations |
|
0.01 |
– |